WFDC2 and ovarian carcinoma: In a more recent meta-analysis, cell-free DNA appeared to be slightly better than CA 125 and similar to HE4 with respect to its diagnostic ability to discriminate individuals with from those without ovarian cancer (Li et al., 2019).